Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
FACE (Fascial Abdominal Closure Evaluation) Trial is a prospective, single center, open-label, randomized trial of Duramesh versus PDS loop suture for midline incision fascial abdominal closure evaluation in patients with gynecological malignancies
Incisional hernias after midline incisions are estimated are estimated around 10-20%, which many times results in further surgical procedures. Many techniques with different sutures have been proposed of the years for fascial closure. PDS suture offers longer dissolution time, lower short-term tensile strength and lower knot security, however the highest quality data available for gynecological malignancies are from 30 years ago. On the other hand, the use of mesh suture (Duramesh) has been proposed as an alternative, in order to reduce postoperative hernias and abdominal wall complication rates. A recent systematic review on Duramesh shows promising results with a median incisional hernia occurrence of 3.4%, but the authors highlight the need for high-quality randomized controlled trials with long-term follow-up to evaluate the clinical benefits of Duramesh.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ARM A: Control Arm | Active Comparator | (Ethicon) PDS II 1-0 double loop suture material with a 48mm needle |
|
| ARM B: Intervention Arm | Experimental | Duramesh suture with a 48mm needle |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| DURAMESH | Device | Duramesh is a non-absorbable polypropylene "mesh suture": a suture that is built like a tiny mesh tube so it behaves both as a suture and as a small piece of mesh to strengthen tissue closure |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of incisional hernia | Clinical or radiological detected | Up to 12 months after randomization |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of wound dehiscence | Up to 1 month after randomization | |
| Incidence of wound infection | Up to 1 months after randomization | |
| Visual Analogue Scale (VAS) for wound pain |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dimitrios Zouzoulas, MD, MSc, PhD | Contact | +306946536065 | dzouzoulas@hotmail.gr |
| Name | Affiliation | Role |
|---|---|---|
| Dimitrios Tsolakidis, Dr. Prof. | Aristotle University Of Thessaloniki | Principal Investigator |
Not provided
Sharing of IPD only after contact with the principal investigator for the synthesis of future studies
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000069290 | Incisional Hernia |
| ID | Term |
|---|---|
| D006547 | Hernia |
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D011183 | Postoperative Complications |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| (Ethicon) PDS II 1-0 double loop | Device | (Ethicon) PDS II 1-0 double loop suture with a 48 mm needle is a slowly absorbable, synthetic monofilament polydioxanone suture designed to provide prolonged tensile support for fascial and other soft-tissue closure where extended wound support is desired |
|
Wound pain will be assessed with the Visual Analogue Scale (VAS). The minimum value is 0 (no pain) and the maximum value is 10 (Pain as bad as it could possibly be). The VAS line is 10cm long. Higher scores mean a worse outcome. |
| Fifth postoperative day after randomization |
| D010335 | Pathologic Processes |